entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
101060691,NUTM2B-AS1,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,370.205879429291,-0.245746450820628,0.116666548433223,-2.10640028457931,0.0351695966035793,0.196684001942812,NA
101060691,NUTM2B-AS1,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,98.2743684098299,-0.125611038739715,0.187547067421943,-0.669757413253044,0.503012445568187,0.96308222060722,patient-derived GBM cell lines (PDGCLs)
101060691,NUTM2B-AS1,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,151.82617861204,-0.222830363201202,0.169727404601308,-1.31287203574834,0.189226071285355,0.535169276051013,A549
101060691,NUTM2B-AS1,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,168.516968372767,-0.0565595804503989,0.164341020735191,-0.34415984638148,0.730726077753687,0.986418245486816,A549
101060691,NUTM2B-AS1,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,275.511505236728,0.43501335856946,0.196503892157228,2.21376459160104,0.026844977020683,0.0792431330296915,A549
101060691,NUTM2B-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,220.76872003794,-0.0962804765736616,0.180681363957615,-0.532874417509089,0.594120515284426,1,sigmoid colon organoid
101060691,NUTM2B-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,220.76872003794,0.0261690355908817,0.179648430300749,0.145668044786543,0.884183448803865,1,sigmoid colon organoid
